北美药代动力学服务市场预测至 2031 年 - 区域分析 - 按药物类型（小分子、大分子和疫苗）、服务类型（临床前 ADME 和人体研究、PK/PD 分析和报告、剂量模拟、风险分析等）、治疗应用（肿瘤学、传染病、神经系统疾病、自身免疫性疾病、妇科疾病、心血管疾病、呼吸系统疾病等）和最终用户（制药和生物技术公司、合同研究组织等）

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Analysis - by Drug Type (Small Molecule, Large Molecule, and Vaccines), Service Type (Pre-Clinical ADME and Human Studies, PK/PD Analysis and Reporting, Dosing Simulations, Risk Analysis, and Others), Therapeutic Application (Oncology, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Gynecological Disorders, Cardiovascular Diseases, Respiratory Disorders, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others)

No. of Pages: 87    |    Report Code: BMIRE00030931    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Pharmacokinetics Services Market
Free Sample Buy Now
2023 年北美药代动力学服务市场价值为 3.7536 亿美元，预计到 2031 年将达到 6.9277 亿美元；预计 2023 年至 2031 年的复合年增长率为 8.0%。

药代动力学研究应用范围不断扩大，推动北美药代动力学服务市场发展

药代动力学研究用于确定几个参数，例如人体等效剂量 (HED) 水平、未观察到效应水平 (NOEL) 和药代动力学/药效学测试。进行的任何临床前项目的主要重点是支持对药代动力学研究中测试的安全有效剂量范围的分析。几项毒理学研究对 NOEL 进行了数据处理，即不会产生不良影响的最高剂量。如果缺乏临床药代动力学数据，则根据比较体表面积将该剂量水平进一步转换为 HED 水平。了解潜在候选药物的药代动力学特征在药物发现计划中起着重要作用。监管机构在推动药代动力学研究的实施方面发挥着重要作用。这些研究还有助于优化为住院患者提供的药物护理服务。PK 模型通常用于确定药物暴露量、药物浓度以分析最佳剂量，并分析药物在人体内的分布。医疗保健提供者实施 PK 原理来设计监测药物浓度、某些药物的剂量，最大限度地实现预期的治疗效果并最大限度地降低毒性。

北美药代动力学服务市场概览

美国在北美药代动力学服务市场中占有最大份额。该国已成为领先的临床研究目的地；它占全球临床试验总数的约 50%。完善的医疗基础设施、快速的审批流程和有利的监管框架为制药研究公司开展临床试验创造了有利环境。此外，在美国进行的试验产生的数据在全球范围内得到认可。根据世界卫生组织 (WHO) 的报告，美国在 2021 年登记的临床试验数量最多 (157,618)。

北美药代动力学服务市场收入和预测到 2031 年（百万美元）

北美药代动力学服务市场细分

北美药代动力学服务市场分为药物类型、服务类型、治疗应用、最终用户和国家。

根据药物类型，北美药代动力学服务市场分为小分子、大分子和疫苗。小分子细分市场在 2023 年占据最大市场份额。

就服务类型而言，北美药代动力学服务市场分为临床前 ADME 和人体研究、PK/PD 分析和报告、剂量模拟、风险分析等。临床前 ADME 和人体研究细分市场在 2023 年占据最大市场份额。

按治疗应用，北美药代动力学服务市场细分为肿瘤学、传染病、神经系统疾病、自身免疫性疾病、妇科疾病、心血管疾病、呼吸系统疾病等。肿瘤学细分市场在 2023 年占据最大市场份额。

按最终用户，北美药代动力学服务市场细分为制药和生物技术公司、合同研究组织等。合同研究组织部门在 2023 年占据了最大的市场份额。

按国家/地区划分，北美药代动力学服务市场分为美国、加拿大和墨西哥。2023 年，美国占据了北美药代动力学服务市场份额的主导地位。

Charles River Laboratories International Inc；Eurofins Scientific SE；Evotec SE；Certara Inc.；Parexel International Corp；Thermo Fisher Scientific Inc.；Allucent；PACIFIC BIOLABS；和 SGS SA 是北美药代动力学服务市场的一些领先公司。

North America Pharmacokinetics Services Strategic Insights

Strategic insights for North America Pharmacokinetics Services involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-pharmacokinetics-services-market-strategic-framework.webp
Get more information on this report

North America Pharmacokinetics Services Report Scope

Report Attribute Details
Market size in 2023 US$ 375.36 Million
Market Size by 2031 US$ 692.77 Million
Global CAGR (2023 - 2031) 8.0%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 药物类型
  • 小分子
  • 大分子
  • 疫苗
By 服务类型
  • 临床前 ADME 和人体研究
  • PK/PD 分析和报告
  • 剂量模拟
  • 风险分析
By 最终用户
  • 制药和生物技术公司
  • 合同研究组织
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Charles River Laboratories International Inc
  • Eurofins Scientific SE
  • Evotec SE
  • Certara Inc.
  • Parexel International Corp
  • Thermo Fisher Scientific Inc.
  • Allucent
  • PACIFIC BIOLABS
  • SGS SA
    		•
    Get more information on this report

    North America Pharmacokinetics Services Regional Insights

    The regional scope of North America Pharmacokinetics Services refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-pharmacokinetics-services-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - North America Pharmacokinetics Services Market

    1. Charles River Laboratories International Inc
    2. Eurofins Scientific SE
    3. Evotec SE
    4. Certara Inc.
    5. Parexel International Corp
    6. Thermo Fisher Scientific Inc.
    7. Allucent
    8. PACIFIC BIOLABS
    9. SGS SA
    Frequently Asked Questions
    How big is the North America Pharmacokinetics Services Market?

    The North America Pharmacokinetics Services Market is valued at US$ 375.36 Million in 2023, it is projected to reach US$ 692.77 Million by 2031.

    What is the CAGR for North America Pharmacokinetics Services Market by (2023 - 2031)?

    As per our report North America Pharmacokinetics Services Market, the market size is valued at US$ 375.36 Million in 2023, projecting it to reach US$ 692.77 Million by 2031. This translates to a CAGR of approximately 8.0% during the forecast period.

    What segments are covered in this report?

    The North America Pharmacokinetics Services Market report typically cover these key segments-

  • 药物类型 (小分子, 大分子, 疫苗)
  • 服务类型 (临床前 ADME 和人体研究, PK/PD 分析和报告, 剂量模拟, 风险分析)
  • 最终用户 (制药和生物技术公司, 合同研究组织)

    • What is the historic period, base year, and forecast period taken for North America Pharmacokinetics Services Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Pharmacokinetics Services Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
    • Who are the major players in North America Pharmacokinetics Services Market?

    The North America Pharmacokinetics Services Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Charles River Laboratories International Inc
  • Eurofins Scientific SE
  • Evotec SE
  • Certara Inc.
  • Parexel International Corp
  • Thermo Fisher Scientific Inc.
  • Allucent
  • PACIFIC BIOLABS
  • SGS SA
    • Who should buy this report?

    The North America Pharmacokinetics Services Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Pharmacokinetics Services Market value chain can benefit from the information contained in a comprehensive market report.

    north-america-pharmacokinetics-services-market